BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25426644)

  • 1. Anchorage independency promoted tumor malignancy of melanoma cells under reattachment through elevated interleukin-8 and CXC chemokine receptor 1 expression.
    Uen WC; Hsieh CH; Tseng TT; Jiang SS; Tseng JC; Lee SC
    Melanoma Res; 2015 Feb; 25(1):35-46. PubMed ID: 25426644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of cell invasiveness through PKC-mediated syndecan-1 downregulation in melanoma cells under anchorage independency.
    Wang C; Tseng T; Jhang Y; Tseng J; Hsieh C; Wu WG; Lee S
    Exp Dermatol; 2014 Nov; 23(11):843-9. PubMed ID: 25236603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness.
    Kunz M; Hartmann A; Flory E; Toksoy A; Koczan D; Thiesen HJ; Mukaida N; Neumann M; Rapp UR; Bröcker EB; Gillitzer R
    Am J Pathol; 1999 Sep; 155(3):753-63. PubMed ID: 10487833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced chemosensitization of anoikis-resistant melanoma cells through syndecan-2 upregulation upon anchorage independency.
    Tseng T; Uen W; Tseng J; Lee S
    Oncotarget; 2017 Sep; 8(37):61528-61537. PubMed ID: 28977882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-8 secreted by endothelial cells induces chemotaxis of melanoma cells through the chemokine receptor CXCR1.
    Ramjeesingh R; Leung R; Siu CH
    FASEB J; 2003 Jul; 17(10):1292-4. PubMed ID: 12738812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
    Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
    Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL8 and its cognate receptors in melanoma progression and metastasis.
    Singh S; Singh AP; Sharma B; Owen LB; Singh RK
    Future Oncol; 2010 Jan; 6(1):111-6. PubMed ID: 20021212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasma membrane Ca
    Hegedũs L; Garay T; Molnár E; Varga K; Bilecz Á; Török S; Padányi R; Pászty K; Wolf M; Grusch M; Kállay E; Döme B; Berger W; Hegedũs B; Enyedi A
    Int J Cancer; 2017 Jun; 140(12):2758-2770. PubMed ID: 27813079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials.
    Li A; Varney ML; Singh RK
    Clin Cancer Res; 2001 Oct; 7(10):3298-304. PubMed ID: 11595728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
    Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
    Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.
    Liu X; Peng J; Sun W; Yang S; Deng G; Li F; Cheng JW; Gordon JR
    Tohoku J Exp Med; 2012 Oct; 228(2):147-56. PubMed ID: 23019013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8.
    Araki K; Shimura T; Yajima T; Tsutsumi S; Suzuki H; Okada K; Kobayashi T; Raz A; Kuwano H
    J Biol Chem; 2009 Nov; 284(47):32305-11. PubMed ID: 19801670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicellular tumor spheroids of human uveal melanoma induce genes associated with anoikis resistance, lipogenesis, and SSXs.
    Ness C; Garred Ø; Eide NA; Kumar T; Olstad OK; Bærland TP; Petrovski G; Moe MC; Noer A
    Mol Vis; 2017; 23():680-694. PubMed ID: 29033534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.
    Gabellini C; Trisciuoglio D; Desideri M; Candiloro A; Ragazzoni Y; Orlandi A; Zupi G; Del Bufalo D
    Eur J Cancer; 2009 Sep; 45(14):2618-27. PubMed ID: 19683430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor.
    Pocza P; Süli-Vargha H; Darvas Z; Falus A
    Int J Cancer; 2008 May; 122(9):1972-80. PubMed ID: 18076073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6-induced Twist and N-cadherin enhance melanoma cell metastasis.
    Na YR; Lee JS; Lee SJ; Seok SH
    Melanoma Res; 2013 Dec; 23(6):434-43. PubMed ID: 24051540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
    Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
    Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2.
    Zaslaver A; Feniger-Barish R; Ben-Baruch A
    J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
    Luca M; Huang S; Gershenwald JE; Singh RK; Reich R; Bar-Eli M
    Am J Pathol; 1997 Oct; 151(4):1105-13. PubMed ID: 9327744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo.
    Javelaud D; Delmas V; Möller M; Sextius P; André J; Menashi S; Larue L; Mauviel A
    Oncogene; 2005 Nov; 24(51):7624-9. PubMed ID: 16007121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.